Track the 박셀바이오 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 박셀바이오 has published 37 reports. Market capitalisation: €94.3bn. The latest transaction was filed on 27 March 2026 (Purchase). Among the most active insiders: 이제중. All data is accessible without an account.
37
Insider Decl.
n/a
Thresholds
€4,477
19 ops.
Buy Volume
n/a
5 ops.
Sell Volume
31Σ signal
Buys €4,477n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.